• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Focused ultrasound ablation goes after brain tumors

Article

High-intensity focused ultrasound ablation has been tried successfully in soft-tissue tumors in the breast, prostate, kidneys, and liver. The next frontier is the brain.

High-intensity focused ultrasound ablation has been tried successfully in soft-tissue tumors in the breast, prostate, kidneys, and liver. The next frontier is the brain.

The researchers at Iowa State University have developed a computational model to assess the technique through heterogeneous tissue. A $350,000 grant from the Roy J. Carver Charitable Trust will move the investigators to the next phase: testing the application in humans.

"We need to predict what the ultrasound beam will do when it goes through so many layers of tissue. You want to cook only the tumor and not the surrounding cells," said principal investigator Viren Amin, Ph.D.

Researchers also want to define protocols for specific tumor types and intend to use MR and ultrasound imaging to plan for focused ultrasound treatments.

Recent Videos
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.